SCOPUS 정보 검색 플랫폼

Mediterranean Journal of Hematology and Infectious Diseases

Volumn 5, Issue 1, 2013, Pages 1-8

Endothelial Nitric Oxide Synthase (enos) gene polymorphism is associated with age onset of menarche in sickle cell disease females of India

(1) Nishank, Sudhansu Sekhar a

a INDIAN COUNCIL OF MEDICAL RESEARCH (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; GENOMIC DNA; GUANINE; NITRITE; THYMINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE;

AGE DISTRIBUTION; ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENOS GENE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENETIC ASSOCIATION; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INDIA; MENARCHE; ONSET AGE; POLYMERASE CHAIN REACTION; PREVALENCE; QUANTITATIVE ANALYSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SICKLE CELL ANEMIA; ADOLESCENT; BLOOD LEVEL; CHILD; ELISA KIT; GENE FREQUENCY; GENOTYPE; SCHOOL CHILD;

EID: 84890524941 PISSN: None EISSN: 20353006 Source Type: Journal
DOI: 10.4084/MJHID.2013.036 Document Type: Article

Times cited : (8)

References (29)

1
- 84862664371
- EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
- European Association for the Study of the Liver
- European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection. J Hepatol. 2012; 57: 167-85.
- (2012) J Hepatol , vol.57 , pp. 167-85

2
- 70349240414
- Chronic Hepatitis B: update 2009
- Lok AS, McMahon BJ. Chronic Hepatitis B: update 2009. Hepatology. 2009; 50: 661-2. http://dx.doi.org/10.1002/hep.23190
- (2009) Hepatology , vol.50 , pp. 661-2
- Lok, A.S.¹ McMahon, B.J.²

3
- 33846447769
- A randomized controlled trial of lamivudine to treat acute hepatitis B
- Kumar M, Satapathy S, Monga R, Das K, Hissar S, Pande C, Sharma BC, Sarin SK. A randomized controlled trial of lamivudine to treat acute hepatitis B. Hepatology 2007; 45: 97-101. http://dx.doi.org/10.1002/hep.21486
- (2007) Hepatology , vol.45 , pp. 97-101
- Kumar, M.¹ Satapathy, S.² Monga, R.³ Das, K.⁴ Hissar, S.⁵ Pande, C.⁶ Sharma, B.C.⁷ Sarin, S.K.⁸

4
- 19944375424
- Lamivudine treatment for acute severe hepatitis B: A pilot study
- Schmilovitz-Weiss H, Ben-Ari Z, Sikuler E, Zuckerman E, Sbeit W, Ackerman Z, Safadi R, Lurie Y, Rosner G, Tur-Kaspa R, Reshef R. Lamivudine treatment for acute severe hepatitis B: A pilot study. Liver Int 2004; 24: 547-51. http://dx.doi.org/10.1111/j.1478-3231.2004.0983.x
- (2004) Liver Int , vol.24 , pp. 547-51
- Schmilovitz-Weiss, H.¹ Ben-Ari, Z.² Sikuler, E.³ Zuckerman, E.⁴ Sbeit, W.⁵ Ackerman, Z.⁶ Safadi, R.⁷ Lurie, Y.⁸ Rosner, G.⁹ Tur-Kaspa, R.¹⁰ Reshef, R.¹¹

5
- 44449097685
- Acute hepatitis B: is antiviral therapy indicated? Two case reports
- Girke J, Wedemeyer H, Wiegand J, Manns MP, Tillmann HL. Acute hepatitis B: is antiviral therapy indicated? Two case reports. Dtsch Med Wochenschr. 2008; 133: 1178-82. http://dx.doi.org/10.1055/s-2008-1077235
- (2008) Dtsch Med Wochenschr , vol.133 , pp. 1178-82
- Girke, J.¹ Wedemeyer, H.² Wiegand, J.³ Manns, M.P.⁴ Tillmann, H.L.⁵

6
- 84871084326
- Severe acute hepatitis B in a treatment-naïve patient with antiviral drug resistant mutations in the polymerase gene
- Morando F, Rosi S, Fasolato S, Cavallin M, Gola E, Gatta A, Angeli P. Severe acute hepatitis B in a treatment-naïve patient with antiviral drug resistant mutations in the polymerase gene. J Med Virol. 2013; 85: 210-3. http://dx.doi.org/10.1002/jmv.23448
- (2013) J Med Virol , vol.85 , pp. 210-3
- Morando, F.¹ Rosi, S.² Fasolato, S.³ Cavallin, M.⁴ Gola, E.⁵ Gatta, A.⁶ Angeli, P.⁷

7
- 84855561898
- Fulminant hepatic failure by hepatitis B virus in a patient with human immunodeficiency virus infection: report of one case
- Sagredo S, Mancilla C, Estuardo N, Poniachik J. Fulminant hepatic failure by hepatitis B virus in a patient with human immunodeficiency virus infection: report of one case. Rev Med Chil. 2011; 139: 1336-9. http://dx.doi.org/10.4067/S0034-98872011001000013
- (2011) Rev Med Chil , vol.139 , pp. 1336-9
- Sagredo, S.¹ Mancilla, C.² Estuardo, N.³ Poniachik, J.⁴

8
- 80052949868
- Successful tenofovir treatment for fulminant hepatitis B infection in an infant
- Diamanti A, Sartorelli MR, Alterio A, Comparcola D, Corsetti T, Iacono A, Pizzichemi G, Nobili V, De Ville de Goyet J, Torre G. Successful tenofovir treatment for fulminant hepatitis B infection in an infant. Pediatr Infect Dis J. 2011; 30: 912-4. http://dx.doi.org/10.1097/INF.0b013e31821e23b3
- (2011) Pediatr Infect Dis J , vol.30 , pp. 912-4
- Diamanti, A.¹ Sartorelli, M.R.² Alterio, A.³ Comparcola, D.⁴ Corsetti, T.⁵ Iacono, A.⁶ Pizzichemi, G.⁷ Nobili, V.⁸ De Ville de Goyet, J.⁹ Torre, G.¹⁰

9
- 53049093354
- Lamivudine treatment improves the prognosis of fulminant hepatitis B
- Miyake Y, Iwasaki Y, Takaki A, Fujioka S, Takaguchi K, Ikeda H, Kobashi H, Sakaguchi K, Shiratori Y. Lamivudine treatment improves the prognosis of fulminant hepatitis B. Intern Med. 2008; 47: 1293.9. http://dx.doi.org/10.2169/internalmedicine.47.1061
- (2008) Intern Med , vol.47
- Miyake, Y.¹ Iwasaki, Y.² Takaki, A.³ Fujioka, S.⁴ Takaguchi, K.⁵ Ikeda, H.⁶ Kobashi, H.⁷ Sakaguchi, K.⁸ Shiratori, Y.⁹

10
- 33645083207
- Safety and ef_cacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience
- Tillmann HL, Hadem J, Leifeld L, Zachou K, Canbay A, Eisenbach C, Graziadei L, Encke J, Schmidt H, Vogel W, Schneider A, Spengler U, Gerken G, Dalekos GN, Wedemeyer H, Manns MP. Safety and ef_cacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience. J Viral Hepat. 2006; 13: 256.63. http://dx.doi.org/10.1111/j.1365-2893.2005.00695.x
- (2006) J Viral Hepat , vol.13
- Tillmann, H.L.¹ Hadem, J.² Leifeld, L.³ Zachou, K.⁴ Canbay, A.⁵ Eisenbach, C.⁶ Graziadei, L.⁷ Encke, J.⁸ Schmidt, H.⁹ Vogel, W.¹⁰ Schneider, A.¹¹ Spengler, U.¹² Gerken, G.¹³ Dalekos, G.N.¹⁴ Wedemeyer, H.¹⁵ Manns, M.P.¹⁶

11
- 84858288892
- Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat?
- Tillmann HL, Zachou K, Dalekos GN. Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat? Liver Int. 2012; 32: 544-53. http://dx.doi.org/10.1111/j.1478-3231.2011.02682.x
- (2012) Liver Int , vol.32 , pp. 544-53
- Tillmann, H.L.¹ Zachou, K.² Dalekos, G.N.³

12
- 79952479772
- Lamivudine treatment is associated with improved survival in fulminant hepatitis B
- Yu JW, Sun LJ, Yan BZ, Kang P, Zhao YH. Lamivudine treatment is associated with improved survival in fulminant hepatitis B. Liver Int. 2011; 31: 499-506. http://dx.doi.org/10.1111/j.1478-3231.2011.02450.x
- (2011) Liver Int , vol.31 , pp. 499-506
- Yu, J.W.¹ Sun, L.J.² Yan, B.Z.³ Kang, P.⁴ Zhao, Y.H.⁵

13
- 77949332709
- The study of efficacy of lamivudine in patients with severe acute hepatitis B
- Yu JW, Sun LJ, Zhao YH. The study of efficacy of lamivudine in patients with severe acute hepatitis B. Dig Dis Sci. 2010; 55: 775-83 http://dx.doi.org/10.1007/s10620-009-1060-5
- (2010) Dig Dis Sci , vol.55 , pp. 775-783
- Yu, J.W.¹ Sun, L.J.² Zhao, Y.H.³

14
- 0033803799
- Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis B
- Hadziyannis SJ, Papatheodoridis GV, Dimou E, Laras A, Papaioannou C. Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis B. Hepatology. 2000; 32: 847.51. http://dx.doi.org/10.1053/jhep.2000.17915
- (2000) Hepatology , vol.32
- Hadziyannis, S.J.¹ Papatheodoridis, G.V.² Dimou, E.³ Laras, A.⁴ Papaioannou, C.⁵

15
- 0000126797
- Clinical significance of YMDD mutant hepatitis B virus (HBV) in a large cohort of lamivudine-treated hepatitis B patients
- Atkins M, Hunt CM, Brown N, Gray F, Sanathanan L, Woessner M, Lai CL, Dusheiko G, Dienstag J, Wright T, Barnard J, Bourne E, Condreay L. Clinical significance of YMDD mutant hepatitis B virus (HBV) in a large cohort of lamivudine-treated hepatitis B patients. Hepatology. 1998; 28: 319A
- (1998) Hepatology , vol.28
- Atkins, M.¹ Hunt, C.M.² Brown, N.³ Gray, F.⁴ Sanathanan, L.⁵ Woessner, M.⁶ Lai, C.L.⁷ Dusheiko, G.⁸ Dienstag, J.⁹ Wright, T.¹⁰ Barnard, J.¹¹ Bourne, E.¹² Condreay, L.¹³

16
- 77950124622
- Prevalence and clinical characterization of patients with acute hepatitis B induced by lamivudine-resistant strains
- Hayashi K, Katano Y, Ishigami M, Itoh A, Hirooka Y, Nakano I, Yoshioka K, Yano M, Toyoda H, Kumada T, Goto H. Prevalence and clinical characterization of patients with acute hepatitis B induced by lamivudine-resistant strains. J Gastroenterol Hepatol. 2010; 25: 745-49. http://dx.doi.org/10.1111/j.1440-1746.2009.06118.x
- (2010) J Gastroenterol Hepatol , vol.25 , pp. 745-49
- Hayashi, K.¹ Katano, Y.² Ishigami, M.³ Itoh, A.⁴ Hirooka, Y.⁵ Nakano, I.⁶ Yoshioka, K.⁷ Yano, M.⁸ Toyoda, H.⁹ Kumada, T.¹⁰ Goto, H.¹¹

17
- 77954658782
- Acute hepatitis B infection associated with drug-resistant hepatitis B virus
- Xu Z, Liu Y, Xu T, Chen L, Si L, Wang Y, Ren X, Zhong Y, Zhao J, Xu D. Acute hepatitis B infection associated with drug-resistant hepatitis B virus. J Clin Virol. 2010; 48: 270-74. http://dx.doi.org/10.1016/j.jcv.2010.05.010
- (2010) J Clin Virol , vol.48 , pp. 270-74
- Xu, Z.¹ Liu, Y.² Xu, T.³ Chen, L.⁴ Si, L.⁵ Wang, Y.⁶ Ren, X.⁷ Zhong, Y.⁸ Zhao, J.⁹ Xu, D.¹⁰

18
- 84865550789
- Clinical characteristics and chronicity of acute hepatitis B induced by lamivudine-resistant strains
- Luo Q, Zhong Y, Yang Y, Xiong Q, Hu Z, Lu W, Huang P, Zhang N. Clinical characteristics and chronicity of acute hepatitis B induced by lamivudine-resistant strains. J Med Virol. 2012; 84: 1558-61. http://dx.doi.org/10.1002/jmv.23369
- (2012) J Med Virol , vol.84 , pp. 1558-61
- Luo, Q.¹ Zhong, Y.² Yang, Y.³ Xiong, Q.⁴ Hu, Z.⁵ Lu, W.⁶ Huang, P.⁷ Zhang, N.⁸

19
- 84872419777
- Evaluation of anti-HBV drug resistant mutations among patients with acute symptomatic hepatitis B in the United States
- Baxa DM, Thekdi AD, Golembieski A, Krishnan PV, Sharif O, Kizy A, Shetron-Rama L, Jovanovich J, Chappell BJ, Snow-Lampart A, Borroto-Esoda K, Gordon SC. Evaluation of anti-HBV drug resistant mutations among patients with acute symptomatic hepatitis B in the United States. J Hepatol. 2013; 58: 212-6. http://dx.doi.org/10.1016/j.jhep.2012.09.014
- (2013) J Hepatol , vol.58 , pp. 212-6
- Baxa, D.M.¹ Thekdi, A.D.² Golembieski, A.³ Krishnan, P.V.⁴ Sharif, O.⁵ Kizy, A.⁶ Shetron-Rama, L.⁷ Jovanovich, J.⁸ Chappell, B.J.⁹ Snow-Lampart, A.¹⁰ Borroto-Esoda, K.¹¹ Gordon, S.C.¹²

20
- 70349892270
- Hepatitis B-associated acute liver failure: immediate treatment with entecavir inhibits hepatitis B virus replication and potentially its sequelae
- Jochum C, Gieseler RK, Gawlista I, Fiedler A, Manka P, Saner FH, Roggendorf M, Gerken G, Canbay A. Hepatitis B-associated acute liver failure: immediate treatment with entecavir inhibits hepatitis B virus replication and potentially its sequelae. Digestion. 2009; 80: 235-40. http://dx.doi.org/10.1159/000236009
- (2009) Digestion , vol.80 , pp. 235-40
- Jochum, C.¹ Gieseler, R.K.² Gawlista, I.³ Fiedler, A.⁴ Manka, P.⁵ Saner, F.H.⁶ Roggendorf, M.⁷ Gerken, G.⁸ Canbay, A.⁹

21
- 70849096538
- Entecavir to treat severe acute hepatitis B
- De Socio GV, Mercuri A, Di Candilo F, Baldelli F. Entecavir to treat severe acute hepatitis B. Scand J Infect Dis. 2009; 41: 703-4. http://dx.doi.org/10.1080/00365540903062705
- (2009) Scand J Infect Dis , vol.41 , pp. 703-4
- De Socio, G.V.¹ Mercuri, A.² Di Candilo, F.³ Baldelli, F.⁴

22
- 84925405476
- Severe acute hepatitis B treated with entecavir
- De Socio GV, Sgrelli A, Tosti A, Baldelli F. Severe acute hepatitis B treated with entecavir. Mediterr J Haemotol Infect Dis. 2011; 3: e2011010. http://dx.doi.org/10.4084/mjhid.2011.010
- (2011) Mediterr J Haemotol Infect Dis , vol.3
- De Socio, G.V.¹ Sgrelli, A.² Tosti, A.³ Baldelli, F.⁴

23
- 38049006331
- Tenofovir renal safety in HIV-infected patients: results from the SCOLTA Project
- CISAI Group
- Madeddu G, Bonfanti P, De Socio GV, Carradori S, Grosso C, Marconi P, Penco G, Rosella E, Miccolis S, Melzi S, Mura MS, Landonio S, Ricci E, Quirino T; CISAI Group. Tenofovir renal safety in HIV-infected patients: results from the SCOLTA Project. Biomed Pharmacother. 2008; 62: 6-11. http://dx.doi.org/10.1016/j.biopha.2007.04.008
- (2008) Biomed Pharmacother , vol.62 , pp. 6-11
- Madeddu, G.¹ Bonfanti, P.² De Socio, G.V.³ Carradori, S.⁴ Grosso, C.⁵ Marconi, P.⁶ Penco, G.⁷ Rosella, E.⁸ Miccolis, S.⁹ Melzi, S.¹⁰ Mura, M.S.¹¹ Landonio, S.¹² Ricci, E.¹³ Quirino, T.¹⁴

24
- 84875976383
- Hypophosphatemic osteomalacoa associated with tenofovir: a multidisciplinary approach is required
- De Socio GVL, Fabbriciani G, Massarotti M, Messina S, Cecchini E, Marasini B. Hypophosphatemic osteomalacoa associated with tenofovir: a multidisciplinary approach is required. Mediterr J Hematol Infect Dis. 2012; 4: e2012025. http://dx.doi.org/10.4084/mjhid.2012.025
- (2012) Mediterr J Hematol Infect Dis , vol.4
- De Socio, G.V.L.¹ Fabbriciani, G.² Massarotti, M.³ Messina, S.⁴ Cecchini, E.⁵ Marasini, B.⁶

25
- 34848858648
- Four year assessment of entecavir resistance in nucleoside-naïve and lamivudine-refractory patients [Abstract]
- Colonno RJ, Rose RE, Pokornowski K. Four year assessment of entecavir resistance in nucleoside-naïve and lamivudine-refractory patients [Abstract]. J Hepatol. 2007; 46: S294
- (2007) J Hepatol , vol.46
- Colonno, R.J.¹ Rose, R.E.² Pokornowski, K.³

26
- 33847683844
- Two-year assessment of entecavir resistance in lamivudine-refractory hepatitis B virus patients reveals different clinical outcomes depending on the resistance substitutions present
- Tenney DJ, Rose RE, Baldick CJ, Levine SM, Pokornowski KA, Walsh AW, Fang J, Yu CF, Zhang S, Mazzucco CE, Eggers B, Hsu M, Plym MJ, Poundstone P, Yang J, Colonno RJ. Two-year assessment of entecavir resistance in lamivudine-refractory hepatitis B virus patients reveals different clinical outcomes depending on the resistance substitutions present. Antimocrob Agents Chemother. 2007; 51: 902-911. http://dx.doi.org/10.1128/AAC.00833-06
- (2007) Antimocrob Agents Chemother , vol.51 , pp. 902-911
- Tenney, D.J.¹ Rose, R.E.² Baldick, C.J.³ Levine, S.M.⁴ Pokornowski, K.A.⁵ Walsh, A.W.⁶ Fang, J.⁷ Yu, C.F.⁸ Zhang, S.⁹ Mazzucco, C.E.¹⁰ Eggers, B.¹¹ Hsu, M.¹² Plym, M.J.¹³ Poundstone, P.¹⁴ Yang, J.¹⁵ Colonno, R.J.¹⁶

27
- 69549138465
- Entecavir monotherapy for lamivudinerefractory chronic hepatitis B
- Goulis I, Dalekos GN. Entecavir monotherapy for lamivudinerefractory chronic hepatitis B. Expert Rev Anti Infect Ther. 2008; 6: 855-9. http://dx.doi.org/10.1586/14787210.6.6.855
- (2008) Expert Rev Anti Infect Ther , vol.6 , pp. 855-9
- Goulis, I.¹ Dalekos, G.N.²

28
- 78651104675
- Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B
- Patterson SJ, George J, Strasser SI, Lee AU, Sievert W, Nicoll AJ, Desmond PV, Roberts SK, Locarnini S, Bowden S, Angus PW. Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B. Gut. 2011; 60: 247-254. http://dx.doi.org/10.1136/gut.2010.223206
- (2011) Gut , vol.60 , pp. 247-254
- Patterson, S.J.¹ George, J.² Strasser, S.I.³ Lee, A.U.⁴ Sievert, W.⁵ Nicoll, A.J.⁶ Desmond, P.V.⁷ Roberts, S.K.⁸ Locarnini, S.⁹ Bowden, S.¹⁰ Angus, P.W.¹¹

29
- 73449121925
- Longterm efficacy of tenofovir monotherapy for hepatitis B virusmonoinfected patients after failure of nucleoside/nucleotide analogues
- Van Bömmel F, De Man RA, Wedemeyer H, Deterding K, Petersen J, Buggisch P, Erhardt A, Hüppe D, Stein K, Trojan J, Sarrazin C, Böcher WO, Spengler U, Wasmuth HE, Reinders JG, Möller B, Rhode P, Feucht HH, Wiedenmann B, Berg T. Longterm efficacy of tenofovir monotherapy for hepatitis B virusmonoinfected patients after failure of nucleoside/nucleotide analogues. Hepatology. 2010; 51: 73-80. http://dx.doi.org/10.1002/hep.23246
- (2010) Hepatology , vol.51 , pp. 73-80
- Van Bömmel, F.¹ De Man, R.A.² Wedemeyer, H.³ Deterding, K.⁴ Petersen, J.⁵ Buggisch, P.⁶ Erhardt, A.⁷ Hüppe, D.⁸ Stein, K.⁹ Trojan, J.¹⁰ Sarrazin, C.¹¹ Böcher, W.O.¹² Spengler, U.¹³ Wasmuth, H.E.¹⁴ Reinders, J.G.¹⁵ Möller, B.¹⁶ Rhode, P.¹⁷ Feucht, H.H.¹⁸ Wiedenmann, B.¹⁹ Berg, T.²⁰ more..

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.